Substance Use Disorders: A Comprehensive Review and Update 2021

February 15, 2021 to February 17, 2021

Now Virtual!

Attend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.

Substance use disorders are complex and have a huge impact on patients, families and communities. They challenge even experienced health care professionals to stay current with evolving guidelines. And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.

That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.

Pricing

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 4, 2021): $595.00
Early Bird Registration (on or before January 25, 2021): $695.00
Regular Registration (after January 25, 2021): $795.00

Other Professionals or Trainees
Super Early Bird Registration (on or before January 4, 2021): $495.00
Early Bird Registration (on or before January 25, 2021): $595.00
Regular Registration (after January 25, 2021): $695.00

Buprenorphine Waiver Training (Sunday, February 14, 2021): $50
This is a ticketed event, NO CME CREDIT

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.***

Syllabus

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by January 24, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Target Audience

This program is intended for:

General and Family Physicians
Psychiatrists
Nurse Practitioners
Physician Assistants
Nurses
Psychologists
Social Workers

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

Describe the best practices for treatment of substance use disorders
Discuss how to properly screen and diagnose substance use disorders
List rational, evidence based pharmacologic and non-pharmacologic therapies for patients with substance use disorders
Assess relative utility and strengths of recovery oriented models of care • Assess and treat patients with co-morbid substance use, mood disorders, anxiety disorders, ADHD, pain, and infectious diseases.
Discuss how to manage complicated withdrawal
Utilize motivational interviewing, CBT and contingency management techniques when working with patients suffering from substance use disorders
Describe the effects of and interventions for marijuana and synthetics
List the different approaches and challenges associated with opioid, alcohol and nicotine treatment
Discuss the challenges associated with identification and management of substance use disorders in the emergency department

Course summary

Available credit:

20.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 20.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
20.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 20.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
20.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 20.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90149
20.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
20.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 20.00 Continuing Education (CE) credits per presentation for psychologists.

Registration opens:

08/01/2020

Course closes:

03/10/2023

Event starts:

02/15/2021 - 8:00am EST

Event ends:

02/17/2021 - 3:50pm EST

Cost:

$675.00

Add to calendar:

Rating:

Substance Use Disorders: A Comprehensive Review and Update

February 14 – 17, 2021

PROGRAM AGENDA

SUNDAY, FEBRUARY 14, 2021

2:00 – 6:00 PM Buprenorphine (MAT) Waiver Training
Laura G. Kehoe, MD, MPH, FASAM

THIS IS A TICKETED EVENT, NO CME CREDIT

MONDAY, FEBRUARY 15, 2021

8:00 – 8:10 AM Welcome & Introduction
David H. Rubin, MD

MODULE TOPIC 1: Etiologies of Substance Use Disorder

8:10– 8:30 AM Neurobiology of Addiction
Timothy E. Wilens, MD

8:30 - 8:50 AM Genetics of Substance Use Disorders
Robert R. Althoff, MD, PhD

8:50 – 9:10 AM Evolutionary Theories of Substance Use
David H. Rubin, MD

MODULE TOPIC 2: General Principles and Care Delivery

9:10 – 9:30 AM Screening and Early Intervention
Christopher Shaw, NP

9:30 – 9:50 AM Treating Addiction as a Chronic Disease
Jessica Gray, MD

9:50 – 10:10 AM Harm Reduction
Dinah Applewhite, MD

10:10 – 10:30 AM Break

10:30 – 10: 50 AM Emergency Room Assessment of Addiction
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP

10:50 – 11:10 AM The Impact of COVID on Treatment Access and Delivery
Eugene Lambert, MD

11:10 – 11: 30 AM Racial & Ethnic Disparities in Substance Use Disorders
Corrie Vilsaint, PhD

11:30 – 12:10 PM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Christopher Shaw, NP, Dinah Applewhite, MD, Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP, Eugene Lambert, MD, Corrie Vilsaint, PhD, Jessica Gray, MD

12:10 – 1:10 PM Lunch Break

MODULE TOPIC 3: Empirically Supported Psychosocial Treatment and Continuum of Care

1:10 – 1:30 PM Motivational Interviewing
John F. Kelly, PhD

1:30 – 1:50 PM CBT
John F. Kelly, PhD

1:50 – 2:10 PM CRAFT (Including Parents)
Martha Kane, PhD

2:10 – 2:30 PM Family Case Discussion
James McKowen, PhD

2:30 – 3:10 PM Panel Discussion
Moderator: Martha Kane, PhD
Panelists: John F. Kelly, PhD, James McKowen, PhD

3:10 – 3:30 PM Break

MODULE TOPIC 4: Recovery Support Services

3:30 – 3:50 PM Self-Help
John F. Kelly, PhD

3:50 – 4:10 PM Recovery Coaching
Martha Kane, PhD

4:10 – 4:30 PM E-Technologies
Brandon G. Bergman, PhD

4:30 – 5:10 PM Panel Discussion
Moderator: John F. Kelly, PhD
Panelists: Martha Kane, PhD, Brandon G. Bergman, PhD

5:10 PM Adjourn

TUESDAY, FEBRUARY 16, 2021

8:00 – 8:10 AM Introduction
Timothy E. Wilens, MD

MODULE TOPIC 5: Nicotine

8:10 – 8:30 AM Nicotine Use in Kids
Randi Schuster, MD

8:30 – 8:50 AM Vaping
Randi Schuster, MD

8:50 – 9:10 AM Nicotine and NRTs
Shamim H. Nejad, MD

9:10 – 9:50 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Randi Schuster, MD, Shamim H. Nejad, MD

9:50 – 10:10 AM Break

MODULE TOPIC 6: Sedatives and Alcohol Use Disorders

10:10 – 10:30 AM Outpatient Management of Alcohol Use Disorder
Laura G. Kehoe, MD, MPH, FASAM

10:30 – 10:50 AM Inpatient Management of Alcohol Withdrawal Syndromes
Mladen Nisavic, MD

10:50 – 11:10 AM Sedatives and Hypnotics
Robert R. Althoff, MD, PhD

11:10 – 11:50 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Laura G. Kehoe, MD, MPH, FASAM, Mladen Nisavic, MD, Robert R. Althoff, MD, PhD

11:50 – 12:50 PM Lunch Break

MODULE TOPIC 7: Stimulants

12:50 – 1:10 PM Methamphetamine
Timothy E. Wilens, MD

1:10 – 1:30 PM Cocaine, Rx Stimulants
Timothy E. Wilens, MD

1:30 – 2:10 PM Panel Discussion
Moderator: Jessica Gray, MD
Panelists: Timothy E. Wilens

2:10 – 2:30 PM Break

MODULE TOPIC 8: OPIOIDS

2:30 – 2:50 PM Overview of Opioid Use Disorder
Sarah Wakeman, MD

2:50 – 3:10 PM Buprenorphine 101
Laura G. Kehoe, MD, MPH, FASAM

3:10 – 3:30 PM Microdosing and Extended Release Buprenorphine
Evan Gale, MD

3:30 – 3:50 PM Pain
Jessica Gray, MD

3:50 – 4:10 PM Pregnancy
Davida Schiff, MD, MSc

4:10 – 4:50 PM Panel Discussion
Moderator: Laura G. Kehoe, MD, MPH, FASAM
Panelists: Sarah Wakeman, MD, Evan Gale, MD, Jessica Gray, MD, Davida Schiff, MD, MSc

4:50 PM Adjourn

WEDNESDAY, FEBRUARY 17, 2021

8:00 – 8:10 AM Introduction
David H. Rubin, MD

MODULE TOPIC 9: Marijuana

8:10 – 8:30 AM Cannabis Use & Use Disorders
Timothy E. Wilens, MD

8:30 – 8:50 AM Clinical Management
Robert R. Althoff, MD, PhD

8:50 – 9:30 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Robert R. Althoff, MD, PhD

9:30 – 9:50 AM Break

MODULE TOPIC 10: Polysubstance Use

9:50 – 10:10 AM Fundamentals of Polysubstance Use
Timothy E. Wilens, MD

10:10 – 10:30 AM Polysubstance Use Cases
Laura G. Kehoe, MD, MPH, FASAM

10:30 – 11:10 AM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Timothy E. Wilens, MD,
Laura G. Kehoe, MD, MPH, FASAM

11:10 – 12:10 PM Lunch Break

MODULE TOPIC 11: Comorbidity

12:10 – 12:30 AM ADHD
Timothy E. Wilens, MD

12:30 – 12:50 PM Mood Disorders
Mladen Nisavic, MD

12:50 – 1:10 PM Anxiety Disorders
Shamim H. Nejad, MD

1:10 – 1:30 PM Trauma
Abigail Judge, PhD

1:30 – 2:10 PM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Shamim H. Nejad, MD, Mladen Nisavic, MD, Abigail Judge, PhD

2:10 – 2:30 PM Break

MODULE TOPIC 12: Hallucinogens

2:30 – 2:50 PM Hallucinogens
Franklin King, MD

2:50 – 3:10 PM Psychedelics from Misuse to Therapeutics
Franklin King, MD

3:10 – 3:50 PM Panel Discussion
Moderator: David Rubin, MD
Panelists: Franklin King, MD

3:50 PM Adjourn

Course Director(s)